troglitazone has been researched along with Alcoholic Fatty Liver in 2 studies
Troglitazone: A chroman and thiazolidinedione derivative that acts as a PEROXISOME PROLIFERATOR-ACTIVATED RECEPTORS (PPAR) agonist. It was formerly used in the treatment of TYPE 2 DIABETES MELLITUS, but has been withdrawn due to hepatotoxicity.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Oniki, K | 1 |
| Ueda, K | 1 |
| Hori, M | 1 |
| Mihara, S | 1 |
| Marubayashi, T | 1 |
| Nakagawa, K | 1 |
| Everett, L | 1 |
| Galli, A | 1 |
| Crabb, D | 1 |
1 review available for troglitazone and Alcoholic Fatty Liver
| Article | Year |
|---|---|
The role of hepatic peroxisome proliferator-activated receptors (PPARs) in health and disease.
Topics: Animals; Chemical and Drug Induced Liver Injury; Chromans; Fatty Liver, Alcoholic; Kupffer Cells; Li | 2000 |
1 other study available for troglitazone and Alcoholic Fatty Liver
| Article | Year |
|---|---|
Glutathione-S-transferase (GST) M1 null genotype and combined GSTM1 and GSTT1 null genotypes as a risk factor for alcoholic mild liver dysfunction.
Topics: Chromans; Fatty Liver, Alcoholic; Gene Frequency; Genotype; Glutathione Transferase; Humans; Hypogly | 2007 |